Clinical Trial Update: A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating different doses of BI 765049 alone and in combination with Ezabenlimab in Asian patients with advanced solid tumors …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastrointestinal Cancer
• Head and Neck Cancer
• Liver Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• BI 765049 (BI-765049)
• ezabenlimab (ezabenlimab)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Gastrointestinal Cancer, Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING